A new low-nephron CKD model with hypertension, progressive decline of renal function, and enhanced inflammation in C57BL/6 mice

American Journal of Physiology - Renal Physiology

Volumn 314, Issue 5, 2018, Pages F1008-F1019

  Wei, Jin ^a   Zhang, Jie ^a   Wang, Lei ^a   Cha, Byeong Jake ^a   Jiang, Shan ^a   Liu, Ruisheng ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Chronic kidney disease

Indexed keywords

CREATININE; INTERLEUKIN 17; INTERLEUKIN 6; LECTIN; RENIN; TUMOR NECROSIS FACTOR; AUTACOID; BIOLOGICAL MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CHRONIC KIDNEY FAILURE; CONFOCAL LASER SCANNING MICROSCOPY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FLUORESCENCE; GLOMERULUS FILTRATION RATE; HISTOLOGY; HYPERTENSION; INFLAMMATION; INFLAMMATORY INFILTRATE; KIDNEY ARTERY; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY INFARCTION; KIDNEY INJURY; KIDNEY SLICE; LEUKOCYTE COUNT; MEAN ARTERIAL PRESSURE; MOUSE; NEPHRON; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEINURIA; TRANSMISSION ELECTRON MICROSCOPY; UNINEPHRECTOMY; UPREGULATION; ALBUMINURIA; ANIMAL; ARTERIAL PRESSURE; BLOOD; C57BL MOUSE; COMPARATIVE STUDY; DISEASE EXACERBATION; DISEASE MODEL; KIDNEY; LIGATION; NEPHRECTOMY; PATHOLOGY; PATHOPHYSIOLOGY; RENOVASCULAR HYPERTENSION; SURGERY; TIME FACTOR; ULTRASTRUCTURE; URINE; VASCULARIZATION;

ALBUMINURIA; ANIMALS; ARTERIAL PRESSURE; BIOMARKERS; CREATININE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GLOMERULAR FILTRATION RATE; HYPERTENSION, RENOVASCULAR; INFLAMMATION; INFLAMMATION MEDIATORS; KIDNEY; LIGATION; MICE, INBRED C57BL; NEPHRECTOMY; RENAL ARTERY; RENAL INSUFFICIENCY, CHRONIC; RENIN; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85057649895     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00574.2017     Document Type: Article

References (62)

1. Akchurin OM, Kaskel F. Update on inflammation in chronic kidney disease. Blood Purif 39: 84-92, 2015. doi:10.1159/000368940.
2. Al Banchaabouchi M, Marescau B, D’Hooge R, Van Marck E, Van Daele A, Levillain O, De Deyn PP. Biochemical and histopathological changes in nephrectomized mice. Metabolism 47: 355-361, 1998. doi:10.1016/S0026-0495(98)90271-2.
3. Anderson S, Rennke HG, Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77: 1993-2000, 1986. doi:10.1172/JCI112528.
4. Antopolsky M, Simanovsky N, Stalnikowicz R, Salameh S, Hiller N. Renal infarction in the ED: 10-year experience and review of the literature. Am J Emerg Med 30: 1055-1060, 2012. doi:10.1016/j.ajem.2011.06.041.
5. Betjes MG. Immune cell dysfunction and inflammation in end-stage renal disease. Nat Rev Nephrol 9: 255-265, 2013. doi:10.1038/nrneph.2013.44.
6. Bourgault M, Grimbert P, Verret C, Pourrat J, Herody M, Halimi JM, Karras A, Amoura Z, Jourde-Chiche N, Izzedine H, François H, Boffa JJ, Hummel A, Bernadet-Monrozies P, Fouque D, Canouï-Poitrine F, Lang P, Daugas E, Audard V. Acute renal infarction: a case series. Clin J Am Soc Nephrol 8: 392-398, 2013. doi:10.2215/CJN.05570612.
7. Bourgoignie JJ, Gavellas G, Martinez E, Pardo V. Glomerular function and morphology after renal mass reduction in dogs. J Lab Clin Med 109: 380-388, 1987.
8. Cachofeiro V, Goicochea M, de Vinuesa SG, Oubiña P, Lahera V, Luño J. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int Suppl 74, Suppl: S4-S9, 2008. doi:10.1038/ki.2008.516.
9. Coburn JW, Gonick HC, Rubini ME, Kleeman CR. Studies of experimental renal failure in dogs. I. Effect OF 5-6 nephrectomy on concentrating and diluting capacity of residual nephrons. J Clin Invest 44: 603-614, 1965. doi:10.1172/JCI105173.
10. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS. Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047, 2007. doi:10.1001/jama.298.17.2038.
11. Eddy AA, Falk RJ, Sibley RK, Hostetter TH. Subtotal nephrectomy in the rabbit: a model of chronic hypercalcemia, nephrolithiasis, and obstructive nephropathy. J Lab Clin Med 107: 508-516, 1986.
12. Fogo AB. Animal models of FSGS: lessons for pathogenesis and treatment. Semin Nephrol 23: 161-171, 2003. doi:10.1053/snep.2003.50015.
13. Gao Q, Shen W, Qin W, Zheng C, Zhang M, Zeng C, Wang S, Wang J, Zhu X, Liu Z. Treatment of db/db diabetic mice with triptolide: a novel therapy for diabetic nephropathy. Nephrol Dial Transplant 25: 3539-3547, 2010. doi:10.1093/ndt/gfq245.
14. Gilbertson DT, Liu J, Xue JL, Louis TA, Solid CA, Ebben JP, Collins AJ. Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol 16: 3736-3741, 2005. doi:10.1681/ASN.2005010112.
15. Griffin KA, Picken M, Bidani AK. Method of renal mass reduction is a critical modulator of subsequent hypertension and glomerular injury. J Am Soc Nephrol 4: 2023-2031, 1994.
16. Guasti L, Dentali F, Castiglioni L, Maroni L, Marino F, Squizzato A, Ageno W, Gianni M, Gaudio G, Grandi AM, Cosentino M, Venco A. Neutrophils and clinical outcomes in patients with acute coronary syndromes and/or cardiac revascularisation. A systematic review on more than 34,000 subjects. Thromb Haemost 106: 591-599, 2011. doi:10.1160/TH11-02-0096.
17. Guo M, Ricardo SD, Deane JA, Shi M, Cullen-McEwen L, Bertram JF. A stereological study of the renal glomerular vasculature in the db/db mouse model of diabetic nephropathy. J Anat 207: 813-821, 2005. doi:10.1111/j.1469-7580.2005.00492.x.
18. Gupta J, Mitra N, Kanetsky PA, Devaney J, Wing MR, Reilly M, Shah VO, Balakrishnan VS, Guzman NJ, Girndt M, Periera BG, Feldman HI, Kusek JW, Joffe MM, Raj DS; CRIC Study Investigators. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin J Am Soc Nephrol 7: 1938-1946, 2012. doi:10.2215/CJN.03500412.
19. Haroun MK, Jaar BG, Hoffman SC, Comstock GW, Klag MJ, Coresh J. Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol 14: 2934-2941, 2003. doi:10.1097/01.ASN.0000095249.99803.85.
20. Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR, Vinh A, Weyand CM. Inflammation, immunity, and hypertension. Hypertension 57: 132-140, 2011. doi:10.1161/HYPERTENSIONAHA.110.163576.
21. Hill PA, Lan HY, Nikolic-Paterson DJ, Atkins RC. ICAM-1 directs migration and localization of interstitial leukocytes in experimental glomerulonephritis. Kidney Int 45: 32-42, 1994. doi:10.1038/ki.1994.4.
22. Hodgkins KS, Schnaper HW. Tubulointerstitial injury and the progression of chronic kidney disease. Pediatr Nephrol 27: 901-909, 2012. doi:10.1007/s00467-011-1992-9.
23. Islam TM, Fox CS, Mann D, Muntner P. Age-related associations of hypertension and diabetes mellitus with chronic kidney disease. BMC Nephrol 10: 17, 2009. doi:10.1186/1471-2369-10-17.
24. Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, Tranaeus A, Stenvinkel P, Lindholm B. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 3: 1526-1533, 2008. doi:10.2215/CJN.00950208.
25. Kazancioğlu R. Risk factors for chronic kidney disease: an update. Kidney Int Suppl (2011) 3: 368-371, 2013. doi:10.1038/kisup.2013.79.
26. Ke Y, Tang H, Ye C, Lei CT, Wang YM, Su H, Zhang C, Jiang HJ. Role and Association of Inflammatory and Apoptotic Caspases in Renal Tubulointerstitial Fibrosis. Kidney Blood Press Res 41: 643-653, 2016. doi:10.1159/000447933.
27. Kilicarslan H, Yildirim S, Bagcivan I, Gokce G, Sarac B, Sarioglu Y. The effect of chronic renal failure on phosphodiesterase inhibitor-induced relaxation responses in rabbit cavernosal strips. Eur J Pharmacol 462: 155-160, 2003. doi:10.1016/S0014-2999(03)01296-2.
28. Kren S, Hostetter TH. The course of the remnant kidney model in mice. Kidney Int 56: 333-337, 1999. doi:10.1046/j.1523-1755.1999.00527.x.
29. Laouari D, Friedlander G, Burtin M, Silve C, Dechaux M, Garabedian M, Kleinknecht C. Subtotal nephrectomy alters tubular function: effect of phosphorus restriction. Kidney Int 52: 1550-1560, 1997. doi:10.1038/ki.1997.485.
30. Leelahavanichkul A, Yan Q, Hu X, Eisner C, Huang Y, Chen R, Mizel D, Zhou H, Wright EC, Kopp JB, Schnermann J, Yuen PS, Star RA. Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model. Kidney Int 78: 1136-1153, 2010. doi:10.1038/ki.2010.287.
31. Lessman RK, Johnson SF, Coburn JW, Kaufman JJ. Renal artery embolism: clinical features and long-term follow-up of 17 cases. Ann Intern Med 89: 477-482, 1978. doi:10.7326/0003-4819-89-4-477.
32. Levey AS, Astor BC, Stevens LA, Coresh J. Chronic kidney disease, diabetes, and hypertension: what’s in a name? Kidney Int 78: 19-22, 2010. doi:10.1038/ki.2010.115.
33. Linden E, Cai W, He JC, Xue C, Li Z, Winston J, Vlassara H, Uribarri J. Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation. Clin J Am Soc Nephrol 3: 691-698, 2008. doi:10.2215/CJN.04291007.
34. López-Novoa JM, Rodríguez-Peña AB, Ortiz A, Martínez-Salgado C, López Hernández FJ. Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications. J Transl Med 9: 13, 2011. doi:10.1186/1479-5876-9-13.
35. Lu Y, Wei J, Stec DE, Roman RJ, Ge Y, Cheng L, Liu EY, Zhang J, Hansen PB, Fan F, Juncos LA, Wang L, Pollock J, Huang PL, Fu Y, Wang S, Liu R. Macula Densa Nitric Oxide Synthase 1β Protects against Salt-Sensitive Hypertension. J Am Soc Nephrol 27: 2346-2356, 2016. doi:10.1681/ASN.2015050515.
36. Migliorini A, Ebid R, Scherbaum CR, Anders HJ. The danger control concept in kidney disease: mesangial cells. J Nephrol 26: 437-449, 2013. doi:10.5301/jn.5000247.
37. Mulay SR, Desai J, Kumar SV, Eberhard JN, Thomasova D, Romoli S, Grigorescu M, Kulkarni OP, Popper B, Vielhauer V, Zuchtriegel G, Reichel C, Bräsen JH, Romagnani P, Bilyy R, Munoz LE, Herrmann M, Liapis H, Krautwald S, Linkermann A, Anders HJ. Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis. Nat Commun 7: 10274, 2016. doi:10.1038/ncomms10274.
38. Paris B, Bobrie G, Rossignol P, Le Coz S, Chedid A, Plouin PF. Blood pressure and renal outcomes in patients with kidney infarction and hypertension. J Hypertens 24: 1649-1654, 2006. doi:10.1097/01.hjh.0000239302.55754.1f.
39. Pauletto P, Rattazzi M. Inflammation and hypertension: the search for a link. Nephrol Dial Transplant 21: 850-853, 2006. doi:10.1093/ndt/gfl019.
40. Perez-Ruiz L, Ros-Lopez S, Cardús A, Fernandez E, Valdivielso JM. A forgotten method to induce experimental chronic renal failure in the rat by ligation of the renal parenchyma. Nephron, Exp Nephrol 103: e126-e130, 2006. doi:10.1159/000092198.
41. Plantinga L, Grubbs V, Sarkar U, Hsu CY, Hedgeman E, Robinson B, Saran R, Geiss L, Burrows NR, Eberhardt M, Powe N; CDC CKD Surveillance Team. Nonsteroidal anti-inflammatory drug use among persons with chronic kidney disease in the United States. Ann Fam Med 9: 423-430, 2011. doi:10.1370/afm.1302.
42. Pupilli C, Chevalier RL, Carey RM, Gomez RA. Distribution and content of renin and renin mRNA in remnant kidney of adult rat. Am J Physiol Renal Physiol 263: F731-F738, 1992. doi:10.1152/ajprenal.1992.263.4.F731.
43. Purkerson ML, Hoffsten PE, Klahr S. Pathogenesis of the glomerulopathy associated with renal infarction in rats. Kidney Int 9: 407-417, 1976. doi:10.1038/ki.1976.50.
44. Ramage IJ, Howatson AG, McColl JH, Maxwell H, Murphy AV, Beattie TJ, Ramage IJ. Glomerular basement membrane thickness in children: a stereologic assessment. Kidney Int 62: 895-900, 2002. doi:10.1046/j.1523-1755.2002.00527.x.
45. Ravera M, Re M, Deferrari L, Vettoretti S, Deferrari G. Importance of blood pressure control in chronic kidney disease. J Am Soc Nephrol 17, Suppl 2: S98-S103, 2006. doi:10.1681/ASN.2005121319.
46. Remuzzi G, Perico N, Macia M, Ruggenenti P. The role of reninangiotensin-aldosterone system in the progression of chronic kidney disease. Kidney Int Suppl 68, Suppl: S57-S65, 2005. doi:10.1111/j.1523-1755.2005.09911.x.
47. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 49: 1603-1616, 2010. doi:10.1016/j.freeradbiomed.2010.09.006.
48. Robertson JL, Goldschmidt M, Kronfeld DS, Tomaszewski JE, Hill GS, Bovee KC. Long-term renal responses to high dietary protein in dogs with 75% nephrectomy. Kidney Int 29: 511-519, 1986. doi:10.1038/ki.1986.29.
49. Schlöndorff D, Banas B. The mesangial cell revisited: no cell is an island. J Am Soc Nephrol 20: 1179-1187, 2009. doi:10.1681/ASN.2008050549.
50. Schreiber A, Shulhevich Y, Geraci S, Hesser J, Stsepankou D, Neudecker S, Koenig S, Heinrich R, Hoecklin F, Pill J, Friedemann J, Schweda F, Gretz N, Schock-Kusch D. Transcutaneous measurement of renal function in conscious mice. Am J Physiol Renal Physiol 303: F783-F788, 2012. doi:10.1152/ajprenal.00279.2012.
51. Shah SV, Baliga R, Rajapurkar M, Fonseca VA. Oxidants in chronic kidney disease. J Am Soc Nephrol 18: 16-28, 2007. doi:10.1681/ASN.2006050500.
52. Shimamura T, Morrison AB. A progressive glomerulosclerosis occurring in partial five-sixths nephrectomized rats. Am J Pathol 79: 95-106, 1975.
53. Silverstein DM. Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease. Pediatr Nephrol 24: 1445-1452, 2009. doi:10.1007/s00467-008-1046-0.
54. Song J, Lu Y, Lai EY, Wei J, Wang L, Chandrashekar K, Wang S, Shen C, Juncos LA, Liu R. Oxidative status in the macula densa modulates tubuloglomerular feedback responsiveness in angiotensin IIinduced hypertension. Acta Physiol (Oxf) 213: 249-258, 2015. doi:10.1111/apha.12358.
55. Tervaert TW, Mooyaart AL, Amann K, Cohen AH, Cook HT, Drachenberg CB, Ferrario F, Fogo AB, Haas M, de Heer E, Joh K, Noël LH, Radhakrishnan J, Seshan SV, Bajema IM, Bruijn JA; Renal Pathology Society. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol 21: 556-563, 2010. doi:10.1681/ASN.2010010010.
56. van den Berg JG, van den Bergh Weerman MA, Assmann KJ, Weening JJ, Florquin S. Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies. Kidney Int 66: 1901-1906, 2004. doi:10.1111/j.1523-1755.2004.00964.x.
57. Vianna HR, Soares CM, Tavares MS, Teixeira MM, Silva AC. [Inflammation in chronic kidney disease: the role of cytokines]. J Bras Nefrol 33: 351-364, 2011. doi:10.1590/S0101-28002011000300012.
58. Wang L, Song J, Buggs J, Wei J, Wang S, Zhang J, Zhang G, Lu Y, Yip KP, Liu R. A new mouse model of hemorrhagic shock-induced acute kidney injury. Am J Physiol Renal Physiol 312: F134-F142, 2017. doi:10.1152/ajprenal.00347.2016.
59. Wang X, Chandrashekar K, Wang L, Lai EY, Wei J, Zhang G, Wang S, Zhang J, Juncos LA, Liu R. Inhibition of nitric oxide synthase 1 induces salt-sensitive hypertension in nitric oxide synthase 1α knockout and wild-type mice. Hypertension 67: 792-799, 2016. doi:10.1161/HYPERTENSIONAHA.115.07032.
60. Yamagami K, Oka T, Wang Q, Ishizu T, Lee JK, Miwa K, Akazawa H, Naito AT, Sakata Y, Komuro I. Pirfenidone exhibits cardioprotective effects by regulating myocardial fibrosis and vascular permeability in pressure-overloaded hearts. Am J Physiol Heart Circ Physiol 309: H512-H522, 2015. doi:10.1152/ajpheart.00137.2015.
61. Yang HC, Zuo Y, Fogo AB. Models of chronic kidney disease. Drug Discov Today Dis Models 7: 13-19, 2010. doi:10.1016/j.ddmod.2010.08.002.
62. Zhang J, Chandrashekar K, Lu Y, Duan Y, Qu P, Wei J, Juncos LA, Liu R. Enhanced expression and activity of Nox2 and Nox4 in the macula densa in ANG II-induced hypertensive mice. Am J Physiol Renal Physiol 306: F344-F350, 2014. doi:10.1152/ajprenal.00515.2013.